The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lucid Diagnostics(NASDAQ:LUCD) 
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly...
Share this website to your friends
Lucid Diagnostics Days Payable Outstanding ttm (DPO)
Lucid Diagnostics Days Receivable Outstanding ttm (DSO)
Lucid Diagnostics Days Inventory Outstanding ttm (DIO)
Lucid Diagnostics Op Cashflow Per Share ttm
Lucid Diagnostics Free Cashflow Per Share ttm
Lucid Diagnostics Cash Per Share ttm
Lucid Diagnostics P/S ratio ttm
Lucid Diagnostics (GAAP) P/E ratio ttm
Lucid Diagnostics P/B ratio ttm
No extra charts and metrics for this ticker.